Clariant 과거 순이익 실적
현재 이 회사의 최신 실적 보고서를 처리하고 있습니다
과거 기준 점검 0/6
Clariant 의 수입은 연평균 -14%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 0.2%의 비율로 증가했습니다. 매출은 연평균 1%의 비율로 감소해 왔습니다.
핵심 정보
-14.02%
순이익 성장률
-13.98%
주당순이익(EPS) 성장률
| Chemicals 산업 성장률 | 5.98% |
| 매출 성장률 | -1.04% |
| 자기자본이익률 | -1.88% |
| 순이익률 | -1.92% |
| 다음 순이익 업데이트 | 31 Jul 2026 |
최근 과거 실적 업데이트
Recent updates
내러티브 업데이트 • May 02
CLN: Trimmed Assumptions And Downgrades Will Shape Measured Forward Expectations
Analysts have trimmed their price target on Clariant by CHF 0.09 to reflect updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E, in line with recent research that includes a downgrade from some firms. Analyst Commentary Bullish Takeaways Bullish analysts see the revised fair value and discount rate assumptions as more realistic.
내러티브 업데이트 • Apr 17
CLN: Earnings Quality And Steadier Cash Generation Will Support Bullish Re Rating
Analysts have trimmed their price target on Clariant to CHF 12.37 from CHF 12.77, citing updated assumptions on discount rates, revenue growth, profit margins and future P/E following recent research, including a downgrade from Goldman Sachs. Analyst Commentary While the latest research includes a downgrade from Goldman Sachs, some views across the Street remain constructive, focusing on how Clariant could still convert its fundamentals into long term value creation.내러티브 업데이트 • Apr 03
CLN: Recent Downgrade And Trimmed Assumptions Will Shape Potential Upside
Analysts have trimmed their CHF price targets for Clariant by a small amount, reflecting more cautious assumptions on revenue growth and profit margins. They are still applying a slightly higher future P/E multiple in their updated models.
내러티브 업데이트 • Mar 20
CLN: Lower CHF 7.80 Outlook Will Restrain Upside As Legal Claims Persist
Analysts have trimmed their average price target on Clariant to CHF 7.80 from CHF 8.00, reflecting slightly softer expectations that align with recent downgrades and more cautious assumptions on growth and returns. Analyst Commentary Recent research points to a more cautious stance on Clariant, with the latest moves reflecting concerns around execution, growth visibility and how the current share price lines up with those risks.내러티브 업데이트 • Mar 05
CLN: Legal Claims And Recent Downgrade Will Frame Potential Upside Ahead
Analysts have trimmed their price expectations for Clariant, with the average target moving modestly lower to around CHF 7.80. This reflects updated assumptions on fair value, discount rates and future P/E in light of recent research calls.내러티브 업데이트 • Feb 19
CLN: Legal Claims And Rating Downgrade Will Shape Measured Future Upside Potential
The updated analyst price target for Clariant now stands at CHF 8.80, a small change from the prior CHF 8.74, as analysts factor in recent target cuts around CHF 7.80 and adjust their assumptions on discount rates, revenue growth, profit margins, and future P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts see the updated CHF 8.80 target as reflecting a more refined view of discount rates and earnings power, rather than a fundamental shift in the story.내러티브 업데이트 • Feb 05
CLN: Lower CHF 7.80 Outlook Will Cap Upside As Legal Claims Linger
Analysts have reduced their price target on Clariant to CHF 7.80 from CHF 8.00 to reflect updated views on the company’s discount rate, revenue growth assumptions, profit margins and future P/E. Analyst Commentary Bearish analysts are signaling a more cautious stance on Clariant by aligning their valuation work with a CHF 7.80 price level.내러티브 업데이트 • Jan 22
CLN: Revised Expectations And Legal Claims Will Shape Future Upside Potential
Analysts have reduced their price target for Clariant to CHF 7.80 from CHF 8.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent research points to a more cautious stance on Clariant, with the price target trimmed to CHF 7.80 from CHF 8 and the rating held steady at Hold.내러티브 업데이트 • Jan 07
CLN: Legal Claims And Steady Earnings Outlook Will Support Bullish Re Rating
Analysts have trimmed their price target on Clariant to CHF 7.80, reflecting updated assumptions for fair value, revenue growth, margins and future P/E multiples following recent research. Analyst Commentary Recent research points to a more measured stance on Clariant, with the revised CHF 7.80 target reflecting updated views on valuation, earnings power and the multiples investors might be willing to pay for the shares.내러티브 업데이트 • Dec 21
CLN: Reduced Price Outlook Will Limit Upside Amid Rising Legal Risks
Analysts have reduced their price target on Clariant by CHF 1.50 to CHF 8.10, reflecting more cautious assumptions on revenue growth and valuation multiples, even though margin expectations have improved slightly. Analyst Commentary Bearish analysts have framed the lower price target as a reflection of rising skepticism around Clariant's ability to deliver on its medium term growth ambitions, despite recent progress on margins.내러티브 업데이트 • Dec 07
CLN: Margin Recovery And Legal Overhang Will Shape Future Share Resilience
Analysts have trimmed their price target on Clariant by CHF 1.50 to reflect a slightly lower assumed future price to earnings multiple and discount rate, even as forecasts for profit margins have improved. Analyst Commentary Analysts remain balanced in their view on Clariant, with modest adjustments to valuation assumptions reflecting both improving profitability and lingering execution risks.내러티브 업데이트 • Nov 23
CLN: Market Recovery And Margin Discipline Will Drive Future Share Resilience
Clariant's analyst price target has been revised downward from CHF 9.78 to CHF 9.51. Analysts cite tempered expectations for near-term performance amid evolving market conditions.내러티브 업데이트 • Nov 07
CLN: Margin Improvements And Efficiency Efforts Will Offset Market Headwinds
Analysts have reduced their price target for Clariant from CHF 9.60 to CHF 8.10. This adjustment reflects lowered growth expectations and a more cautious outlook on the company's future performance.분석 기사 • Nov 04
Cautious Investors Not Rewarding Clariant AG's (VTX:CLN) Performance Completely
There wouldn't be many who think Clariant AG's ( VTX:CLN ) price-to-earnings (or "P/E") ratio of 20.4x is worth a...내러티브 업데이트 • Oct 24
Earnings Recovery Will Depend On Stabilization And Cost Improvements Amid Headwinds
Narrative Update: Clariant Analyst Price Target Adjustment Clariant’s analyst price target has been reduced significantly, dropping from CHF 9.60 to CHF 8.10. Analysts cite softer revenue growth and profit margin expectations in their revised outlook.내러티브 업데이트 • Oct 10
China Expansion And Sustainable Solutions Will Boost Long-Term Appeal
Narrative Update on Clariant Clariant's analyst price target has been revised downward from CHF 10.95 to CHF 10.58. Analysts cite a combination of cautious revenue growth assumptions and a recent reduction in price targets by major banks.내러티브 업데이트 • Sep 26
China Expansion And Sustainable Solutions Will Boost Long-Term Appeal
The minor decrease in Clariant's price target reflects a combination of lower revenue growth expectations and a modestly higher discount rate, resulting in a slight fair value reduction to CHF10.95. What's in the News Clariant AG dropped from the FTSE All-World Index (USD).분석 기사 • Sep 17
Is Clariant AG (VTX:CLN) Trading At A 32% Discount?
Key Insights Clariant's estimated fair value is CHF11.89 based on 2 Stage Free Cash Flow to Equity Current share price...분석 기사 • Aug 26
We Think Clariant (VTX:CLN) Is Taking Some Risk With Its Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Aug 08
Clariant's (VTX:CLN) Anemic Earnings Might Be Worse Than You Think
SWX:CLN 1 Year Share Price vs Fair Value Explore Clariant's Fair Values from the Community and select yours Clariant...분석 기사 • May 30
Clariant (VTX:CLN) Has Affirmed Its Dividend Of CHF0.42
Clariant AG ( VTX:CLN ) has announced that it will pay a dividend of CHF0.42 per share on the 4th of June. Based on...분석 기사 • May 05
These 4 Measures Indicate That Clariant (VTX:CLN) Is Using Debt Extensively
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Apr 13
Are Investors Undervaluing Clariant AG (VTX:CLN) By 39%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Clariant fair value estimate is CHF13.37 Current share price...분석 기사 • Mar 26
Clariant AG's (VTX:CLN) CEO Might Not Expect Shareholders To Be So Generous This Year
Key Insights Clariant's Annual General Meeting to take place on 1st of April Salary of CHF1.20m is part of CEO Conrad...분석 기사 • Mar 05
Clariant AG Just Missed EPS By 6.0%: Here's What Analysts Think Will Happen Next
It's been a sad week for Clariant AG ( VTX:CLN ), who've watched their investment drop 10% to CHF9.76 in the week since...분석 기사 • Mar 02
Take Care Before Diving Into The Deep End On Clariant AG (VTX:CLN)
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") above 21x, you may consider...
새로운 내러티브 • Dec 18
Restructuring, Lucas Meyer Cosmetics, And Sunliquid Set To Boost Margins And Drive Earnings
Identifying restructuring opportunities and targeting significant savings could improve Clariant's net margins and earnings efficiency in the coming years.분석 기사 • Nov 27
Estimating The Intrinsic Value Of Clariant AG (VTX:CLN)
Key Insights The projected fair value for Clariant is CHF10.85 based on 2 Stage Free Cash Flow to Equity Clariant's...분석 기사 • Nov 09
It's A Story Of Risk Vs Reward With Clariant AG (VTX:CLN)
Clariant AG's ( VTX:CLN ) price-to-sales (or "P/S") ratio of 0.9x might make it look like a strong buy right now...분석 기사 • Aug 07
Clariant's (VTX:CLN) Solid Earnings Have Been Accounted For Conservatively
The stock was sluggish on the back of Clariant AG's ( VTX:CLN ) recent earnings report. Our analysis suggests that...분석 기사 • Jul 17
Why Investors Shouldn't Be Surprised By Clariant AG's (VTX:CLN) Low P/S
Clariant AG's ( VTX:CLN ) price-to-sales (or "P/S") ratio of 1.1x might make it look like a strong buy right now...분석 기사 • Apr 23
What Is Clariant AG's (VTX:CLN) Share Price Doing?
Clariant AG ( VTX:CLN ), might not be a large cap stock, but it received a lot of attention from a substantial price...분석 기사 • Apr 03
Increases to Clariant AG's (VTX:CLN) CEO Compensation Might Cool off for now
Key Insights Clariant to hold its Annual General Meeting on 9th of April Total pay for CEO Conrad Keijzer includes...분석 기사 • Nov 22
An Intrinsic Calculation For Clariant AG (VTX:CLN) Suggests It's 50% Undervalued
Key Insights The projected fair value for Clariant is CHF25.95 based on 2 Stage Free Cash Flow to Equity Current share...분석 기사 • Oct 31
Clariant (VTX:CLN) Takes On Some Risk With Its Use Of Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...분석 기사 • Jul 30
Clariant (VTX:CLN) Seems To Use Debt Quite Sensibly
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...매출 및 비용 세부 내역
매출 및 비용 세부 내역
Clariant가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.
순이익 및 매출 추이
| 날짜 | 매출 | 순이익 | 일반관리비 | 연구개발비 |
|---|---|---|---|---|
| 31 Dec 25 | 3,915 | -75 | 717 | 121 |
| 30 Sep 25 | 3,989 | 19 | 777 | 128 |
| 30 Jun 25 | 4,063 | 113 | 820 | 134 |
| 31 Mar 25 | 4,108 | 179 | 779 | 131 |
| 31 Dec 24 | 4,152 | 244 | 754 | 128 |
| 30 Jun 24 | 4,163 | 118 | 697 | 133 |
| 31 Mar 24 | 4,270 | 143 | 668 | 136 |
| 31 Dec 23 | 4,377 | 168 | 639 | 138 |
| 30 Jun 23 | 4,919 | -98 | 677 | 142 |
| 31 Mar 23 | 5,059 | -115 | 711 | 146 |
| 31 Dec 22 | 5,198 | -133 | 745 | 150 |
| 30 Sep 22 | 5,050 | 107 | 725 | 154 |
| 30 Jun 22 | 4,901 | 346 | 705 | 157 |
| 31 Mar 22 | 4,637 | 305 | 700 | 157 |
| 31 Dec 21 | 4,372 | 263 | 694 | 156 |
| 30 Sep 21 | 4,161 | 199 | 672 | 158 |
| 30 Jun 21 | 3,949 | 135 | 649 | 159 |
| 31 Mar 21 | 3,905 | 121 | 665 | 159 |
| 31 Dec 20 | 3,860 | 106 | 681 | 159 |
| 30 Jun 20 | 4,115 | 141 | 1,010 | 166 |
| 31 Mar 20 | 4,257 | 40 | 1,019 | 171 |
| 31 Dec 19 | 4,399 | -62 | 1,027 | 175 |
| 30 Jun 19 | 4,409 | -67 | 865 | 176 |
| 31 Mar 19 | 4,407 | 64 | 861 | 175 |
| 31 Dec 18 | 4,404 | 194 | 856 | 174 |
| 30 Sep 18 | 4,937 | 223 | 922 | 182 |
| 30 Jun 18 | 5,469 | 251 | 987 | 190 |
| 31 Mar 18 | 5,923 | 264 | 1,072 | 197 |
| 31 Dec 17 | 6,377 | 277 | 1,157 | 203 |
| 30 Sep 17 | 6,229 | 276 | 1,130 | 201 |
| 30 Jun 17 | 6,080 | 274 | 1,102 | 199 |
| 31 Mar 17 | 5,964 | 264 | 1,093 | 199 |
| 31 Dec 16 | 5,847 | 253 | 1,084 | 199 |
| 30 Sep 16 | 5,899 | 211 | 1,083 | 208 |
| 30 Jun 16 | 5,835 | 203 | 1,092 | 208 |
| 31 Mar 16 | 5,792 | 195 | 1,063 | 207 |
| 31 Dec 15 | 5,807 | 217 | 1,067 | 204 |
| 30 Sep 15 | 5,867 | 275 | 1,064 | 199 |
| 30 Jun 15 | 5,964 | 272 | 1,061 | 203 |
양질의 수익: CLN 은(는) 현재 수익성이 없습니다.
이익 마진 증가: CLN는 현재 수익성이 없습니다.
잉여현금흐름 대비 순이익 분석
과거 순이익 성장 분석
수익추이: CLN은 수익성이 없으며 지난 5년 동안 손실이 연평균 14% 증가했습니다.
성장 가속화: 현재 수익성이 없어 지난 1년간 CLN의 수익 성장률을 5년 평균과 비교할 수 없습니다.
수익 대 산업: CLN은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(-1.3%)와 비교하기 어렵습니다.
자기자본이익률
높은 ROE: CLN는 현재 수익성이 없으므로 자본 수익률이 음수(-1.88%)입니다.
총자산이익률
투하자본수익률
우수한 과거 실적 기업을 찾아보세요
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/20 13:05 |
| 종가 | 2026/05/20 00:00 |
| 수익 | 2025/12/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Clariant AG는 35명의 분석가가 다루고 있습니다. 이 중 15명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Volker Bosse | Baader Helvea Equity Research |
| Konstantin Wiechert | Baader Helvea Equity Research |
| Katie Richards | Barclays |